NL2016807B1 - System and method for applying microneedles - Google Patents
System and method for applying microneedles Download PDFInfo
- Publication number
- NL2016807B1 NL2016807B1 NL2016807A NL2016807A NL2016807B1 NL 2016807 B1 NL2016807 B1 NL 2016807B1 NL 2016807 A NL2016807 A NL 2016807A NL 2016807 A NL2016807 A NL 2016807A NL 2016807 B1 NL2016807 B1 NL 2016807B1
- Authority
- NL
- Netherlands
- Prior art keywords
- applicator
- support member
- skin
- actuator
- digitally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
Abstract
The invention relates to a microneedle applicator system (1), the system comprising an applicator (4) comprising a housing (101) and an actuator (114) arranged in the housing and arranged to apply a microneedle module (120) via a supporting body (115) onto skin, the actuator being arranged to displace the supporting body between a first position in which the supporting body is positioned inside the housing, and a second position in which the supporting body is moved substantially in line with an opening in the housing or outside the housing. The system further comprises a controller (3) arranged to electronically control the applicator wherein the controller is arranged to adjust the first and/or second position by supplying appropriate power to the actuator.
Description
SYSTEM AND METHOD FOR APPLYING MICRONEEDLES FIELD OF THE INVENTION
The invention relates to a microneedle applicator system, and to a method of applying microneedles onto skin.
BACKGROUND ART
Dermal drug delivery has several advantages over conventional drug delivery methods, especially for drugs with a low bioavailability due to absorption in the gastrointestinal tract and/or due to first pass metabolism. Dermal drug delivery is also advantageous for therapeutic and prophylactic vaccination because the skin is highly immune responsive owing to the large numbers of Langerhans cells and dendritic cells. Furthermore, the skin has a large surface area that is available for drug delivery and is an easily accessible route of administration. However, only about 20 active pharmaceutical ingredients have been formulated in approximately 40 pharmaceutical products for dermal application due to the stratum corneum, which is generally 10-20 pm thick in human and has a low permeability for most drug molecules.
To overcome the stratum corneum several dermal drug delivery systems and devices have been developed, including microarrays or microneedles, which are devices that contain one or more needles with micron-sized dimensions. Several types of microneedle technologies have been developed for dermal and transdermal drug delivery and/or sampling of biological samples from the skin.
Patent publication WO2014092566A1 discloses a method of producing and applying a hollow or solid microneedle made from fused silica capillaries for dermal drug delivery and sampling of biological fluids. W02009072830A2 describes an array of hollow microneedles for drug delivery and sampling of biological fluids via the skin. US8414548B2 describes a method of producing solid microneedle arrays and a device for the application of microneedle arrays onto skin. US20140142541A1 discloses the production and application of an array of dissolving microneedles that contain nanomaterials, which dissolve upon piercing of the skin within five minutes. US20120265145A1 describes dissolving microneedles that dissolve by hydrolysis once the microneedles penetrate skin. US2010280457 discloses a method to coat a microneedle or a microneedle array by applying a high viscosity coating onto the surface of the microneedle. WO2013036115A1 describes a method to coat a microneedle or a microneedle array with a drug by modifying the microneedle surface with nanolayers to minimize the reduction of sharpness upon coating of microneedles. A large variety of microneedles or microneedle arrays have been fabricated with many different geometries. Examples are microneedles that vary in length, sharpness, shape (conical, cylindrical, pyramid, etc.), number of needles per array, density, and these microneedles may be hollow, solid or porous. Microneedles or microneedle arrays can be made of several different materials, such as glass, silicon, stainless steel, titanium, sugar, or polymers. Also, microneedles may be coated with a drug, for example by using highly viscous coating solutions that adhere to the microneedle, thereby leaving thick layers of coatings on the microneedle surface, resulting in a decreased microneedle sharpness and/or increased surface roughness.
The type of microneedle, microneedle geometry and the material from which the microneedles are made can influence their skin penetrating ability. Furthermore, coating of microneedles may result in a decreased sharpness of the microneedles and thereby result in a decreased penetration efficiency of skin by these microneedles.
The common factor for all types of microneedles is that they must pierce the stratum corneum in order to deliver a drug into the skin or obtain a biological sample from the skin. Furthermore, for drug delivery purposes microneedles must penetrate the skin effectively and reproducibly when applied onto skin. Therefore, each type of microneedle or microneedle array should be applied onto skin with its optimal application parameters.
The microneedle material, geometry, and/or coating influence the microneedle strength, sharpness, and/or surface roughness, and thereby its skin penetration ability, and thereby its optimal application parameters. Thus for each type of microneedle device, and/or alteration of the geometry and/or coating of a microneedle device requires investigation and/or reinvestigation of the optimal application parameters.
Several microneedle applicators have been developed. These applicators are generally impact applicators, which are devices that propel microneedles with a certain velocity towards the skin, or applicators that deliver a given amount of pressure via the microneedles onto skin. US 20050261631 discloses a microneedle applicator apparatus which uses springs to apply a drug delivery system onto the skin. US20070027427 discloses a method to apply a drug delivery system onto the skin by using multiple springs in order to first apply a drug delivery system onto the skin and subsequently retract the drug delivery system into the applicator. US20040215151 also discloses an applicator that uses springs to move a drug delivery system onto and from the skin and shrouds the needle after use. These spring-based applicators that are used to apply microneedle modules onto skin by a momentum offer no little control over application parameters. US6611707B1 discloses an applicator to apply microneedles through pressure by manual application. The pressure is obtained by pressing a reservoir by hand to deliver a drug formulation into the skin. Further, US10238958 discloses an applicator which uses hand pressure to drive a plunger which forces a drug formulation through the microneedle into the skin. These types of applicators to apply microneedles by hand pressure onto the skin give little or no control over the application force and other application parameters. W02009077859 does describe a microneedle injecting apparatus which is disclosed to apply drug delivery systems and/or sampling devices onto skin via an electrically-controlled actuator by a momentum. However, the actuator control is mainly via charging and discharging of capacitors, which limits the flexibility and applicability to accurately control the applied momentum and the application time.
SUMMARY OF THE INVENTION
It is an object of the invention to provide a microneedle applicator system which solves at least one of the above mentioned problems of the state of the art. A first aspect of the invention provides a microneedle applicator system.
The system comprises an applicator comprising a housing and an actuator arranged in the housing and arranged to apply a microneedle module via a supporting body onto skin, the actuator being arranged to displace the supporting body between a first position in which the supporting body is positioned inside the housing, and a second position in which the supporting body is moved substantially in line with an opening in the housing or outside the housing. The system further comprises a controller arranged to electronically control the applicator wherein the controller is arranged to adjust the first and/or second position by supplying appropriate power to the actuator.
Electronically setting the positions of the supporting body makes the microneedle applicator system very flexible and gives a user more precise control over the insertion velocity. Furthermore, many different operational modes are made possible.
The microneedle module may be a drug delivery system and/or sampling device. The microneedle module may comprise a single microneedle or multiple microneedles, possibly arranged in an array. The supporting body may be a supporting plateau or any other suitable body arranged to support or attach a needle, a needle array, or a module with needles.
It is noted that the applicator and the controller may be combined into one device, but alternatively they are two or more separate devices communicating with each other.
In an embodiment, a stroke of the actuator and/or force of the actuator is regulated by the power that is supplied to the actuator. Regulating the power supplied to the actuator to control the stroke and/or force supplied results in fine adjustment of the force and/or velocity.
In an embodiment, the actuator comprises a solenoid. In another embodiment, the actuator comprises a voice coil. The advantage of a voice coil in combination with a linear encoder is a precise control over the position of a supporting plateau and/or the velocity by which a supporting plateau propels towards the skin.
In an embodiment, the controller is arranged to regulated the power by switching a transistor via pulse width modulation (PWM) and adjusting the width of the pulse.
In an embodiment, the position of the supporting body is adjustable into: I. a retracted position, and II. a zero-position, and III. a protruded position.
Having a system whereby the position of the supporting plateau is adjustable in the three positions mentioned above, enables an applicator to apply microneedles via different manners of application, i.e., pressure, momentum, and repeated momentum.
In an embodiment, the controller is arranged to receive input from a user in order to select a mode of operation of the applicator, wherein the mode of operation is selectable from at least a first mode and a second mode, wherein in the first mode the applicator is retracted from an extended position to a retracted position as soon as a selectable pressure is detected, and in the second mode the applicator is extended from a retracted position into an extended position with a selectable momentum.
This provides for a device that enables the application of microneedles by the two mostly used methods of application.
In an embodiment, the position of the supporting body is controlled in such a way that: I. in a first state, the position of the actuator is set in such a way that a supporting body protrudes out of the applicator; and II. in a second state, the applicator is applied perpendicular to the skin and is used to press the microneedle module via a supporting body onto skin; and III. in a third state, a supporting body is holding a microneedle module onto skin for a digitally installed period of time; and IV. in a fourth state, a supporting body is retracted into the applicator when a digitally controlled pressure is reached.
In an embodiment, the position of a supporting body is controlled in such a way that: I. in a first state, the position of the actuator is set in such a way that a supporting body is inside the applicator; and II. in a second state, the applicator is placed perpendicularly onto skin; and III. in a third state, the actuator moves a supporting body towards the skin until the supporting body reaches the skin, wherein a supporting body is pressing a microneedle module onto skin until a pre-installed pressure is reached; and IV. in a fourth state, a supporting body is holding a microneedle module onto skin for a digitally installed period of time; and V. in a fifth state, a supporting body is retracted into the applicator
In an embodiment, an adjustable momentum of the supporting body is obtained by: I. in a first state, the supporting body is in a retracted state in the applicator and the applicator is placed perpendicular onto the skin; and II. in a second state, the supporting body is propelled towards a zero position; III. in a third state, the supporting body is retained into a zero-position for a digitally-controlled adjustable period of time; and IV. in a fourth state, the supporting body is retracted into the applicator.
In an embodiment, the supporting body is propelled multiple times with a digitally adjustable application frequency towards the zero position.
Optionally, the application frequency is digitally adjustable between 0.01 mHz and 50 Hz.
In an embodiment, the controller is arranged to digitally adjust the number of insertions between 2 and 106, wherein one insertion cycle is the time that the actuator is in the zero position plus the time that the actuator is (partially) retracted into the housing of the applicator.
In an embodiment, the controller is arranged to digitally adjust a time and/or ratio that the supporting body is in the zero position and (partially) retracted in the housing of the applicator within one insertion cycle.
In an embodiment, the controller is arranged to read a value indicative of an amount of force of the pre-installed pressure onto the supporting body or indicative of a momentum of the actuator from a calibration table.
In an embodiment, the system comprises a pressure sensor, at least in use between the skin and the actuator, and arranged to sense an applied pressure on the supporting body, wherein the controller is arranged to control the power of the applicator using feedback from the pressure sensor.
In an embodiment, the momentum through the supporting body onto skin is regulated by adjusting the velocity by which the supporting body is propelled towards the skin.
In an embodiment, the average velocity between a retracted position and a zero position or the velocity at a zero position is controlled and/or measured by feedback of a sensor. The sensor may be a linear encoder or a piezoelectric element.
In an embodiment, the controller is arranged to execute a software program so as to digitally adjust the time that the supporting body is in such a position and/or delivers a required force to retain a drug delivery and/or sampling device for a preinstalled application time onto the skin.
In an embodiment, the application time is between 1 and 999 milliseconds.
In an embodiment, the application time is between 1 and 50 milliseconds.
In an embodiment, the controller comprises a display, wherein insertion parameters set on the controller and/or readout of the sensors are displayed on the display.
In an embodiment, liquid dispersion and/or sampling is simultaneously regulated with drug delivery and/or sampling device application via one controller.
In an embodiment, liquid dispersion and/or sampling is achieved via a syringe pump. A second aspect of the invention provides a controller for use in a system as described above. A third aspect of the invention provides an applicator for use in a system as described above. A fourth aspect of the invention provides a method of applying microneedles onto skin, the method comprising: - apply a microneedle module via a supporting body onto skin, by using an applicator comprising a housing and an actuator; - displace the supporting body between a first position in which the supporting body is positioned inside the housing, and a second position in which the supporting body is moved substantially in line with an opening in the housing or outside the housing; - electronically control the applicator to adjust the first and/or second position by supplying appropriate power to the actuator.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other aspects of the invention are apparent from and will be elucidated with reference to the embodiments described hereinafter. In the drawings:
Figure 1 schematically shows a system for applying microneedles according to an embodiment;
Figure 2 shows an exploded view of an applicator according to an embodiment;
Figure 3A-3C show three adjustable positions of a supporting plateau of an applicator with a microneedle module attached;
Figure 3D-3F show the three adjustable positions of a supporting plateau of the applicator without the microneedle module attached;
Figure 4A-4F show six states of the applicator with a microneedle module attached or placed onto skin, wherein a predetermined force is used;
Figure 5A-5F show six states of the applicator with a microneedle module attached or placed onto skin, wherein a predetermined momentum is used;
Figure 6 schematically shows an electrical circuit to control an actuator of the applicator via a pulse width modulation;
Figure 7 shows a graph of the force of three different solenoids in different applicators as a function of the actuator power;
Figure 8A shows a graph of the activation time of three different solenoids in different applicators as a function of the actuator power;
Figure 8B shows a graph of the application velocity of three different solenoids in different applicators as a function of the actuator power.
It should be noted that items which have the same reference numbers in different Figures, have the same structural features and the same functions, or are the same signals. Where the function and/or structure of such an item has been explained, there is no necessity for repeated explanation thereof in the detailed description.
DETAILED DESCRIPTION OF EMBODIMENTS
The present invention is a device that encompasses an electronic controller and an applicator to digitally control the manner and the force of application of a microneedle module onto skin.
Drug delivery via the skin can have several advantages over drug delivery via other administration routes, because the skin is easily accessible, has a large available surface area, and delivery via this route can be performed on a minimally invasive manner and is potentially pain free. One of the promising systems for dermal drug delivery and taking biological samples from the skin on a minimally invasive and potentially pain-free manner is by the use of a microneedle or a microneedle array.
In this context a “microneedle” is a micron-sized structure that has preferably a length of less than 1 millimeter which is intended to pierce through the stratum corneum into the epidermis and/or dermis. Further, in this context a microneedle module may refer to a dermal delivery and/or a sampling device, which may include needle like structures with lengths up to several millimeters that are intended to pierce through the stratum corneum into the epidermis and/or dermis. A “microneedle array” refers to a structure that contains more than one microneedle.
In this context, “applying” and/or the “application” of microneedles is intended to inject, insert and/or pierce microneedles into the skin.
Microneedles may be used to permeate skin that may be followed by the application of a topical formulation, may be used to extract biological fluids from the skin, and/or deliver a drug into the skin.
In this context, an applicator is a device that is used to apply a microneedle module onto skin. A controller is referred to as a device that controls the applicator.
In the context of this invention, the skin onto which the microneedle module is applied is animal skin, mammalian skin or human skin.
Figure 1 schematically shows a system for applying microneedles according to an embodiment. The microneedle applicator system 1 comprises a controller 3, an applicator 4 and in this example also a pump 6. Furthermore, the system comprises a temperature sensor 51, a pressure sensor 52 and a position sensor 53. The controller 3 comprises a microcontroller 31 and a user interface 32 which may be a display and/or other user interface equipment, such as buttons and switches.
The applicator 4 comprises an actuator 41 and a supporting body 42 which in this example is a supporting plateau 42. The actuator 41 is arranged to displace the supporting plateau 42 between a first position in which the supporting body is positioned inside a housing (see also Figure 2), and a second position in which the supporting body 42 is moved substantially in line with an opening in the housing or outside the housing. The controller 3 is arranged to electronically control the applicator 4 wherein the controller 3 is arranged to adjust the first and/or second position by supplying appropriate power to the actuator 41.
The pump 6 may be a syringe pump. The pump 6 may be used to deliver fluids to the needles and thereby to the skin. The pump 6 may also be used to sample fluids coming from the skin.
In an embodiment, the controllers is arranged to digitally control the manner of application of a microneedle module onto skin by the applicator 4. This controller-applicator combination may be used to apply microneedle module via a digitally-adjustable momentum, via a digitally-adjustable pressure, or via a repeated momentum onto skin. In an embodiment, the controller 3 is used to digitally adjust the mode of application and the application parameters.
In a preferred embodiment of the invention, the controller contains a microcontroller which is programmed to digitally control the applicator to digitally adjust the manner of application and the application parameters to apply microneedle modules onto skin, as exemplified in Figure 1. These parameters may include the application force, application pressure, application momentum, application velocity, application time, application frequency, number of insertions, and/or time within one application cycle that the supporting plateau is in a zero position or in a retracted position. Further, the controller may simultaneously trigger and/or control an external pump for liquid displacement, either for taking samples or delivering liquids via microneedle modules that are applied onto the skin.
In this context, an “application cycle” is referred to as the time that a supporting plateau is in a zero-position plus the time that a supporting plateau is in a retracted position in a multiple application mode, which is equal to one divided by the application frequency.
Further in this context, the “application frequency” is referred to as the number of application cycles per second, and the “number of insertions” is referred to as the number of application cycles.
In an embodiment of the invention, the application frequency is between 0.01 milli Hertz (mHz) and 50 Hz, preferably between 10 mHz and 25 Hz. Further the number of insertions may vary from two to 10Λ6.
In a further context of this invention, the “zero-/retracted position rate” is referred to as the percentage of time that a supporting plateau is in a zero-position in a complete application cycle.
In an embodiment of this invention the zero-/retracted position rate is digitally-adjustable.
In the context of this invention, the “application time” is referred to as the time that the supporting plateau is in a zero position or in an extended position.
In an embodiment of this invention, the application time may be adjustable from 1 millisecond to multiple days.
In a preferred embodiment of the invention, the controller generates a pulse width modulation of which the duty cycle is adjustable. Suitable frequencies of a pulse width modulation to drive a solenoid or voice coil are above 1 kilo Hertz (kHz), preferably above 10 kHz. A pulse width modulation is used to switch a transistor to regulate the power from a power source that is send to an actuator in an applicator. The actuator may be a solenoid or a voice coil. The power source may be an external power supply.
In the context of this invention the “actuator power” refers to an adjustment of the duty cycle of a pulse width modulation by which a transistor switches a power supply to drive a solenoid or a voice coil.
In a further preferred embodiment of the invention, the transistor that drives the solenoid or voice coil is a power MOSFET. Examples are IRF520N and IRLZ44N.
The applicator comprises a supporting body that has an adjustable position in relation to a skin support, and may be in a retracted position, a zero-position or a protruding position. Figure 3 shows examples of positions of a supporting plateau with and without a microneedle module mounted onto it.
In a further preferred embodiment of the invention, the inner housing of an applicator (Figure 2) contains rubber rings between an inner housing and outer applicator shell to vertically align the inner housing.
In the context of this invention, the “application pressure” is referred to as the pressure by which an actuator applies a microneedle module via a supporting plateau onto skin. The microneedle module may be mounted onto a supporting plateau or may be placed and/or mounted onto the skin, as schematically represented in Figure 4.
In a preferred embodiment of this invention, the application pressure that is obtained by a solenoid or a voice coil is digitally-adjustable by adjusting the actuator power.
In a context of this invention, the “application momentum” may refer to the momentum by which an actuator in an applicator applies a microneedle module that is mounted onto a supporting plateau onto skin, or may refer to the momentum by which an actuator in an applicator applies a microneedle module that is placed and/or mounted onto skin via a supporting plateau, as shown in Figure 5.
In a context of this invention, when microneedle modules are applied onto skin by a digitally-adjustable momentum, the supporting plateau propels towards a zero-position towards the skin with a certain velocity, which is referred to as the “application velocity”. The average application velocity for the application of microneedle modules via a digitally-adjustable momentum is preferably above 5 cm/second.
In a preferred embodiment of this invention, the application momentum that is obtained by a solenoid or a voice coil is digitally-controlled by adjusting the actuator power.
By changing the position of a supporting plateau in a variable time interval from a retracted position towards a zero position by changing the duty cycle of a pulse width modulation, results in propelling the supporting plateau with a certain velocity towards the zero-position.
In a context of this invention, the “actuator distance” is the distance between the position of a supporting plateau that is mounted onto an actuator in a non-extended position and in a fully extended position. This distance for a specific supporting plateau mounted actuator may be predetermined by using a ruler. The “actuator distance” may also be determined by using a position sensor, such as a linear encoder that is coupled to the inner housing and a movable part of the actuator that moves in the same extent as the supporting plateau, which may be used to continuously determine the position of a supporting plateau.
In another context of this invention, the “activation time” is the time between the actuator is digitally-powered and the time that the actuator is in its maximum extended position, which is digitally measured by the controller.
In a preferred embodiment of the invention, the maximum extended position of the actuator-supporting plateau combination is determined by measuring a signal from a piezoelectric element that is inside the applicator outer shell 101, preferably mounted onto the inner housing 107, see figure 2, that will exceed a threshold voltage when the actuator reaches its maximum extended position.
In another preferred embodiment of the invention, the average application velocity is calculated by the controller by dividing the actuator distance by the activation time.
In an embodiment of this invention, a microneedle module is applied onto skin by a digitally-controlled momentum, as schematically represented in Figure 5A-5C. A microneedle module is mounted onto a supporting plateau, which is in a retracted position. The applicator’s skin support is placed perpendicularly onto skin. Upon increasing the actuator power, the supporting plateau onto which a microneedle module is mounted, propels towards a zero-position. This results in application of a microneedle module with a certain velocity onto skin where it is retained until a digitally-installed application time is reached, upon which the supporting plateau, including the microneedle module, moves to a retracted position.
In another embodiment of the invention, the microneedle module is applied onto skin by a digitally controlled momentum, as schematically represented in Figures 5D-5F. A microneedle module is placed and/or mounted onto skin. The applicator’s skin support is placed perpendicularly onto skin. Upon increasing the actuator power, the supporting plateau propels towards a zero-position towards the skin and microneedle module. The supporting plateau is retained in a zero-position until a digitally-installed application time is reached. Finally, the supporting plateau moves to a retracted position, leaving the microneedle module applied onto the skin.
In an embodiment of the invention, an applicator used to apply a microneedle module onto skin by a digitally-adjustable momentum may result in heat production by the actuator at a prolonged application time (> 2 minutes). To reduce heat production the solenoid the actuator power is reduced to a minimum while still able to retain a supporting plateau in a zero-position. Preferably the actuator power is reduced to a minimum after the supporting plateau is in a zero position.
Optionally, the temperature of the actuator in the applicator is monitored by the controller through a temperature sensor that is attached onto or in close proximity of the actuator. When the temperature exceeds a threshold value, the controller may automatically remove the actuator power to prevent overheating of the actuator and/or prevent temperature discomfort when holding the applicator and/or using the applicator to apply a microneedle module onto skin.
An applicator according to an embodiment is shown in Figure 2. This applicator comprises an outer applicator shell 101 that may be hold by hand to apply a microneedle module onto the skin. The top lid 102 of the applicator contains a connector 103 that is used to connect the applicator to a controller to digitally adjust the manner of application and the insertion parameters. Furthermore, on the top lid there is a button 104, of which its state is read by the controller, to digitally activate the applicator when applying a microneedle module onto the skin. On the top lid there is an adjustment bolt 105 that is used to move an inner housing 107 via a screw thread 112 in the displacement cap 113 of the inner housing vertically, up and down within the outer applicator shell. By turning the adjustment bold 360° the inner housing vertically moves approximately 600 micrometer up or down. The inner housing 107 is kept in place by a spring 106 around the adjustment bolt 105. Further, rubber rings 108 are used between an inner housing and outer applicator shell to vertically align the inner housing. Furthermore, the applicator comprises a limiting bolt 109 on the outer applicator shell and limiting nut 110 that is guided through a limiting notch 111 to restrain the movement of the inner housing within the outer applicator shell over a distance of 2 cm. Besides, the actuator in the applicator may be a solenoid 114. Figure 2 shows a rod 116 movable through the solenoid 114. Onto a first outer end of the rod 116 a supporting plateau 115 is mounted that may be aligned with a skin support 100 to apply a dermal microneedle module (not shown) onto skin. On an opposite end of the rod 116 an end stop 118 is mounted and a bias spring 117 is arranged to produce a counter force when the rod 116 is moved due to activation of the solenoid 114.
In an embodiment, the supporting plateau 115 is adjustable into three different positions as shown in Figures 3A-3C which show three adjustable positions of the supporting plateau of the applicator with a microneedle module attached.
The supporting plateau 115 and skin support 100 are exchangeable to fit microneedle modules dependent on their size, whereby the diameter of the skin support is smaller than the diameter of the opening in the skin support.
The applicator 4 that comprises an actuator 200 onto which the supporting plateau 115 is mounted, onto which a microneedle module 120 is attached may be in a retracted position, see Figure 3A, a zero position, see Figure 3B and a protruding position, see Figure 3C, in relation to a skin support 100. By another method of application via pressure, a microneedle module may be placed and/or attached onto the skin, resulting in a possible other zero position of the supporting plateau as compared to a mounted microneedle module. In this case, a supporting plateau without a mounted microneedle module may also be in a retracted position, see Figure 3D, a zero position, see Figure 3E, and a protruding position, see Figure 3F, in relation to a skin support.
When the actuator in the applicator 4 is a solenoid or a voice coil, the position of the supporting plateau 115 may be adjusted to a zero-position or a protruding position when the actuator is fully extended by using an adjustment bolt as represented in Figure 2. The supporting plateau 115 is in a retracted position when the actuator is not fully extended. However, these positions may also be digitally adjustable by changing the duty cycle of a pulse width modulation.
Optionally, the actuator in the applicator may be a solenoid, voice coil, or a stepper motor, wherein the position of the supporting plateau is monitored through a position sensor (such as a linear encoder). The position of a supporting plateau is digitally set to a zero position or a protruding position via the controller through feedback by a position sensor.
The system 1 can be used to apply a microneedle module 120 onto skin 300 by applying a digitally-adjustable pressure, as represented in Figure 4. The actuator may be a solenoid or a voice coil 200. By this manner of application, a microneedle module may be mounted onto a supporting plateau 115 that is mounted onto an actuator, shown in Figures 4A-4C. Initially, a supporting plateau is in a protruded position, see Figure 4A. Next, the supporting plateau onto which a microneedle module is mounted is pressed perpendicularly onto the skin, see Figure 4B. When a digitally-installed pressure is obtained, the supporting plateau partially retracts towards the applicator into a zero position, where it is retained until a digitally-installed application time is reached, upon which the supporting plateau, including the microneedle module, moves into a retracted position, see Figure 4C.
As an alternative to apply a microneedle onto skin by a digitally-adjustable pressure, a microneedle module is placed and/or mounted onto skin as shown in Figure 4D-4F. The actuator may be a solenoid or a voice coil. First, the supporting plateau is in a protruding position, see Figure 4D, and is subsequently pressed perpendicularly onto the microneedle module, see Figure 4E. When the digitally installed pressure is obtained, the supporting plateau partially retracts towards the applicator into a zero-position, where it is retained until a digitally-installed application time is reached. Finally, the supporting plateau moves to a retracted position, leaving the microneedle module applied onto the skin, see Figure 4F.
Optionally, the actuator in an applicator may be a stepper motor or a voice coil, wherein the application pressure is digitally adjusted and regulated via feedback of a pressure sensor. Hereby is a skin support 100 placed perpendicularly onto the skin, wherein a microneedle module is between a supporting plateau and the skin. To apply a microneedle module a supporting plateau moves towards the skin until the digitally installed pressure is obtained. This pressure will be retained until a digitally installed application time is reached upon which the supporting plateau retracts into the applicator.
The system as disclosed in this invention can be used to apply a microneedle module 120 onto skin 300 by applying a digitally-adjustable momentum, as represented in figure 5. The actuator 200 may be a solenoid or a voice coil. By this manner of application, a microneedle module may be mounted onto a supporting plateau 115 that is mounted onto an actuator, shown in Figure 5A-5C. Initially, the supporting plateau is in a retracted position, see Figure 5A. The applicator’s skin support 100 is placed perpendicularly onto skin. Upon increasing the duty cycle of a pulse width modulation, the supporting plateau onto which a microneedle module is mounted, propels towards a zero position, see Figure 5B. This results in application of a microneedle module with a certain velocity onto skin where it is retained until a digitally-installed application time is reached, upon which the supporting plateau, including the microneedle module, moves to a retracted position, see Figure 5C.
As an alternative to apply a microneedle onto skin by a digitally adjustable momentum, a microneedle module is placed and/or mounted onto skin, as shown in Figure 5D-5F. The applicator’s skin support is placed perpendicularly onto skin, see Figure 5D. Upon increasing the duty cycle of a pulse width modulation, the supporting plateau propels towards a zero position towards the skin and microneedle module, see Figure 5E. The supporting plateau is retained in a zero position until a digitally-installed application time is reached. Finally, the supporting plateau moves to a retracted position, leaving the microneedle module applied onto the skin, see Figure 5F.
In an embodiment the electronic controller 3 is arranged to digitally-adjust the manner of application and application parameters by which the applicator applies a microneedle module onto skin, wherein the actuator may be controlled via controlling a pulse width modulation (PWM). As shown in Figure 6, the electronic controller 3 contains an integrated circuit (IC) 500 to digitally generate a PWM 520 at a frequency of at least 1 kHz, but preferably above 10 kHz. The duty cycle of the PWM is used to control the movement and/or position of an actuator 506. This actuator may be a solenoid or a voice coil. A diode 504 in series with a resistor 510 is used to protect the IC against a potential backward voltage by the MOSFET 507. A NPN transistor 509 switches the ground 503 at the PWM frequency. The circuit contains a pull-down resistor 511 between the base of the NPN transistor and the ground and a pull-up resistor 512 between the emitter of the NPN transistor and positive DC voltage 501. Subsequently, the PWM signal arriving from the collector of the NPN arrives at the base of a PNP transistor 508 via a resistor 513 to switch positive DC voltage 501. A voltage divider, comprising a resistor 514 and a variable resistor 515, is used to regulate the switching voltage on the gate of the MOSFET. Finally, the MOSFET drives the actuator that is connected to a positive DV voltage 502 that is paralleled with a fly back diode 505.
Example 1 A controller according to Figure 1 and an applicator according to Figure 2 was used in a mode to deliver a certain amount of force via a supporting plateau (as shown in Figure 4). Three different push-type solenoids were used in three different applicators. The pressure of the three actuators as a function of the actuator power was investigated by adjusting the actuator power and measuring the maximum holding force of the solenoid, with the actuator in a protruded position.
As shown in Figure 7, the pressure of the actuators was controlled by digitally adjusting the actuator power on the controller. By using solenoid X1 the pressure was controlled between 0.95 Newton (1%) and 13.8 Newton (100%) by digitally adjusting the actuator power on the controller. By using solenoid X2 the pressure was controlled between 0.20 Newton (1%) and 8.7 Newton (100%) by digitally adjusting the actuator power on the controller. By using solenoid X3 the pressure was controlled between 1.9 Newton (1%) and 24.5 Newton (30%) by digitally adjusting the actuator power on the controller. Increasing the actuator power for solenoid X3 above 30% resulted in a further increased force, however, the available equipment did not allow us to accurately determine this force.
Example 2 A controller according to Figure 1 and an applicator according to Figure 2 was used in a mode to deliver a certain momentum via a supporting plateau (as shown in Figure 5). Three different push-type solenoids were used in three different applicators. The activation time to move the supporting plateau from a retracted position into a zero-position of the three actuators as a function of the actuator power was measured by the controller, as shown in Figure 8. The actuator distance between the retracted position and the zero-position was measured by using a digital ruler (Solenoid X1: 13.3 mm; Solenoid X2: 8.55 mm; Solenoid X3: 13.5 mm). Subsequently, the average velocity was calculated by dividing the actuator distance by the activation time.
As shown in Figure 8, the momentum of the supporting plateau via the actuators was controlled by digitally adjusting the actuator power on the controller. By using solenoid X1 the average velocity was controlled between 8.3 cm/second (37%) and 52.5 cm/second (100%) by digitally adjusting the actuator power on the controller. By using solenoid X2 the average velocity was controlled between 10.7 cm/second (18%) and 98.9 cm/second (100%) by digitally adjusting the actuator power on the controller. By using solenoid X3 the average velocity was controlled between 21.1 cm/second (22%) and 89.6 cm/second (100%) by digitally adjusting the actuator power on the controller.
An applicator-controller combination as described in the current invention is particularly suitable for researchers, companies and research institutes that develop microneedles to investigate and determine the optimal application parameters of microneedle modules onto skin, but may not be restricted to it.
It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design many alternative embodiments.
In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. Use of the verb "comprise" and its conjugations does not exclude the presence of elements or steps other than those stated in a claim. The article "a" or "an" preceding an element does not exclude the presence of a plurality of such elements. In the device claim enumerating several means, several of these means may be embodied by one and the same item of hardware or software. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage.
Claims (28)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2016807A NL2016807B1 (en) | 2016-05-20 | 2016-05-20 | System and method for applying microneedles |
PCT/EP2017/062238 WO2017198872A1 (en) | 2016-05-20 | 2017-05-22 | System and method for applying microneedles |
US16/303,627 US20200306518A1 (en) | 2016-05-20 | 2017-05-22 | System and method for applying microneedles |
EP17724571.9A EP3458141A1 (en) | 2016-05-20 | 2017-05-22 | System and method for applying microneedles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2016807A NL2016807B1 (en) | 2016-05-20 | 2016-05-20 | System and method for applying microneedles |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2016807B1 true NL2016807B1 (en) | 2017-11-27 |
Family
ID=56852366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2016807A NL2016807B1 (en) | 2016-05-20 | 2016-05-20 | System and method for applying microneedles |
Country Status (1)
Country | Link |
---|---|
NL (1) | NL2016807B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030083645A1 (en) * | 2001-10-26 | 2003-05-01 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040102803A1 (en) * | 2002-04-19 | 2004-05-27 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
WO2004093818A2 (en) * | 2003-04-21 | 2004-11-04 | Stratagent Life Sciences | Apparatus and methods for repetitive microjet drug delivery |
WO2009077859A1 (en) * | 2007-12-14 | 2009-06-25 | Universiteit Leiden | Microneedle injecting apparatus |
US20110172510A1 (en) * | 2010-01-13 | 2011-07-14 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or withdrawal of fluids |
US8414548B2 (en) * | 2006-01-10 | 2013-04-09 | Vadim V. Yuzhakov | Method of making microneedle array and device for applying microneedle array to skin |
WO2014092566A1 (en) * | 2012-12-10 | 2014-06-19 | Universiteit Leiden | Process and device for minimally invasive deep tissue probing |
-
2016
- 2016-05-20 NL NL2016807A patent/NL2016807B1/en not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030083645A1 (en) * | 2001-10-26 | 2003-05-01 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040102803A1 (en) * | 2002-04-19 | 2004-05-27 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
WO2004093818A2 (en) * | 2003-04-21 | 2004-11-04 | Stratagent Life Sciences | Apparatus and methods for repetitive microjet drug delivery |
US8414548B2 (en) * | 2006-01-10 | 2013-04-09 | Vadim V. Yuzhakov | Method of making microneedle array and device for applying microneedle array to skin |
WO2009077859A1 (en) * | 2007-12-14 | 2009-06-25 | Universiteit Leiden | Microneedle injecting apparatus |
US20110172510A1 (en) * | 2010-01-13 | 2011-07-14 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or withdrawal of fluids |
WO2014092566A1 (en) * | 2012-12-10 | 2014-06-19 | Universiteit Leiden | Process and device for minimally invasive deep tissue probing |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8821434B2 (en) | Delivery of a solid body and/or a fluid using a linear Lorentz-force actuated needle-free jet injection system | |
AU2003272279B2 (en) | Measuring properties of an anatomical body | |
CN110325232B (en) | Automatic injection device for fluid products | |
JP5113532B2 (en) | Needleless transdermal delivery device | |
KR102388880B1 (en) | Transdermal delivery of high viscosity bioactive agents | |
KR102071313B1 (en) | Integrated microneedle array delivery system | |
JP6986969B2 (en) | Microneedle system for administering liquid formulations | |
US20050177201A1 (en) | Probe insertion pain reduction method and device | |
JP2016221309A (en) | Injection methods using a servo-controlled needle-free injector | |
US11311670B2 (en) | Automatic injection device having a passive drive system with a shape memory spring | |
US20180326195A1 (en) | Microneedle array and microneedle sheet | |
JP2016517707A (en) | Microneedle applicator with counter assembly | |
US20200306518A1 (en) | System and method for applying microneedles | |
US8770542B2 (en) | Valve for controlling a flow of a fluid through a fluid channel, system and multiple-way valve | |
NL2016807B1 (en) | System and method for applying microneedles | |
US20070118093A1 (en) | High-speed jet devices for drug delivery | |
US20240139484A1 (en) | Test Equipment for Microneedle Systems, and a Test System and a Method for Testing a Microneedle Application | |
Keservani et al. | A novel approach of drug delivery: Microneedles | |
Rathod et al. | Thermal ablation for transdermal drug delivery | |
EP3407957A1 (en) | Device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD | Change of ownership |
Owner name: UPRAX MICROSOLUTIONS B.V.; NL Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT; FORMER OWNER NAME: UPRAX Effective date: 20180914 |
|
MM | Lapsed because of non-payment of the annual fee |
Effective date: 20190601 |